Colaris, Maartje J L, de Boer, Mintsje, van der Hulst, Rene R et al. · Immunologic research · 2017 · DOI
This study compared 200 patients with silicone breast implants who developed autoimmune and inflammatory symptoms (a condition called ASIA) across two time periods—100 patients in 2014 and 100 historical patients from the 1980s–1990s. The researchers found that the symptoms remained similar over 30 years, including fatigue, joint pain, brain fog, and fever. About half of the patients who had their implants removed experienced symptom improvement.
While this study focuses on silicone implants rather than ME/CFS directly, it documents a chronic systemic inflammatory condition with symptom overlap (fatigue, cognitive dysfunction, pain), providing evidence that post-exposure autoimmune syndromes can persist long-term. The finding that explantation benefits 50% of patients offers a model for understanding how removing a putative trigger may benefit patients with immune-mediated diseases, including relevant subgroups in ME/CFS research.
This study does not establish that silicone implants cause ME/CFS, nor does it prove causation—only correlation between implant exposure and ASIA syndrome. The 50% improvement rate after explantation does not prove silicone was the cause in those who improved, as regression to the mean and placebo effects cannot be excluded. This study also does not address whether ME/CFS patients have higher rates of implant exposure or implant-related disease.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →